SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (419)2/27/2003 10:44:04 AM
From: stevenallen  Respond to of 897
 
You bet I can short 'em! Muriel Seibert is the broker I use but I hear there are actually quite a few others who'll also let you do so. Market or limit trades up to 1,000 shares are $15 so the only glitch is the sub $1.00 stocks get a bit pricey commission wise but I rarely play those anyway. They usually have good inventory, but they sometimes hold orders a minute or two so I wouldn't recommend them for the serious daytrader. Gomez.com (if they're still up and running) can give you more info on the full spectrum of brokers to meet your specific needs



To: tuck who wrote (419)2/27/2003 9:28:38 PM
From: Spekulatius  Read Replies (1) | Respond to of 897
 
MEDI's valuation looks pretty rich to me. P/S around 10 for a company that needs to buy itself growth with pretty expensive acquisitions (Aviron) sounds expensive to me. Unless they hit a mother lode with Flumist the stock is far to expensive, IMO. i'd say that the intrinsic value of MEDI is no higher than BGEN, a company with comparable pipeline and revenues. This would imply a stock price of 20$ for MEDI.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News